POM · Pomdoctor
The AI's read
The reported rise describes trading, not a change to Pomdoctor's products, sales, or finances. The article gives no company update, so it does not change how we read Pomdoctor's business.
Pomdoctor was listed among shares that rose 25.6% after the market closed. The article gives no company update, so it does not change the outlook for Pomdoctor's business.
The reported rise describes trading, not a change to Pomdoctor's products, sales, or finances. The article gives no company update, so it does not change how we read Pomdoctor's business.
Phio Pharmaceuticals shares rose 7.65% in the after-market session. The article gives no company update, so it does not change the outlook for Phio Pharmaceuticals' business.
SciSparc shares rose 6.48% in the after-market session. The article gives no company update, so it does not change the outlook for SciSparc's business.
Neumora Therapeutics shares rose 5.69% in the after-market session. The article gives no company update, so it does not change the outlook for Neumora Therapeutics' business.
Kala Bio shares rose 5.42% in the after-market session. The article gives no company update, so it does not change the outlook for Kala Bio's business.
Cumberland Pharma shares fell 10.6% in the after-market session. The article gives no company update, so it does not change the outlook for Cumberland Pharma's business.
Follow Pomdoctor (POM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for POM